A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/22 (2006.01) C07K 14/575 (2006.01)
Patent
CA 2325984
The present invention relates to use of oxidised thymosin .beta.4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also provides pharmaceutical formulations comprising oxidised thymosin .beta.4 together with a suitable excipient.
Utilisation de thymosine .beta.4 oxydée en thérapie, plus particulièrement dans le traitement de maladies ou états pathologiques associés à une réponse inflammatoire ou un choc septique. La présente invention concerne également des compositions pharmaceutiques contenant de la thymosine .beta.4 oxydée ainsi qu'un excipient approprié.
Lawrence Anthony John
Pappin Darryl John Cecil
Stevenson Robert Duncan
Young John
Imperial Cancer Research Technology
Sim & Mcburney
Stevenson Robert Duncan
The University Court Of The University Of Glasgow
LandOfFree
Oxidized thymosin beta 4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxidized thymosin beta 4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxidized thymosin beta 4 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1900585